
Results
269
Most Popular Stocks on the market
269 companies
Samsung BiologicsLtd
Market Cap: ₩71.7t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,548,000.00
7D
-0.5%
1Y
-2.5%
Celltrion
Market Cap: ₩46.1t
A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.
A068270
₩201,000.00
7D
0.9%
1Y
20.6%
ALTEOGEN
Market Cap: ₩21.9t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩314,000.00
7D
3.0%
1Y
-6.6%
Samsung Epis Holdings
Market Cap: ₩10.8t
A biotechnology company, manage the portfolio of biopharmaceutical products.
A0126Z0
₩433,500.00
7D
5.3%
1Y
n/a
SK Biopharmaceuticals
Market Cap: ₩6.8t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩87,300.00
7D
2.2%
1Y
-13.2%
Yuhan
Market Cap: ₩6.2t
Operates as a pharmaceutical company in South Korea and internationally.
A000100
₩83,700.00
7D
3.8%
1Y
-26.8%
Hanmi Pharm
Market Cap: ₩5.1t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩398,500.00
7D
1.5%
1Y
42.6%
ABL Bio
Market Cap: ₩4.7t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩84,100.00
7D
-2.9%
1Y
-3.8%
Peptron
Market Cap: ₩4.5t
Engages in the development of peptide-based medicines.
A087010
₩194,000.00
7D
6.7%
1Y
-45.1%
Sam Chun Dang Pharm
Market Cap: ₩4.4t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩189,000.00
7D
14.8%
1Y
2.1%
LigaChem Biosciences
Market Cap: ₩4.2t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩113,900.00
7D
0.6%
1Y
-27.1%
PharmaResearch
Market Cap: ₩4.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩398,000.00
7D
5.2%
1Y
-41.8%
Voronoi
Market Cap: ₩3.2t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩179,700.00
7D
21.7%
1Y
46.5%
Hanall Biopharma
Market Cap: ₩3.0t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩59,700.00
7D
10.4%
1Y
104.1%
Caregen
Market Cap: ₩3.0t
A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.
A214370
₩61,900.00
7D
-6.2%
1Y
26.2%
SK bioscienceLtd
Market Cap: ₩3.0t
Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.
A302440
₩37,650.00
7D
2.2%
1Y
-19.3%
D&D Pharmatech
Market Cap: ₩2.8t
Engages in the research and development and manufacturing of pharmaceuticals in South Korea.
A347850
₩61,400.00
7D
6.8%
1Y
69.4%
Hugel
Market Cap: ₩2.8t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩256,000.00
7D
-6.4%
1Y
-19.2%
Kolon TissueGene
Market Cap: ₩2.4t
Develops cell therapies for orthopedic diseases and other unmet medical needs.
A950160
₩28,550.00
7D
61.7%
1Y
-27.3%
OliX Pharmaceuticals
Market Cap: ₩2.4t
A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.
A226950
₩112,000.00
7D
-7.6%
1Y
94.1%
ST PharmLtd
Market Cap: ₩2.2t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩106,400.00
7D
6.3%
1Y
14.7%
Mezzion PharmaLtd
Market Cap: ₩2.1t
Develops, manufactures, and sells pharmaceutical products in South Korea.
A140410
₩68,700.00
7D
26.1%
1Y
83.7%
Celltrion Pharm
Market Cap: ₩1.9t
A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.
A068760
₩43,950.00
7D
-0.6%
1Y
-17.0%
Aimed Bio
Market Cap: ₩1.8t
Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.
A0009K0
₩27,250.00
7D
9.0%
1Y
n/a
NatureCellLtd
Market Cap: ₩1.5t
Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.
A007390
₩23,400.00
7D
5.2%
1Y
11.2%
Orum Therapeutics
Market Cap: ₩1.5t
A biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases in South Korea and the United States.
A475830
₩68,100.00
7D
10.0%
1Y
168.6%
L&C BIOLTD
Market Cap: ₩1.5t
Operates as a research and development company in tissue regeneration medicine.
A290650
₩54,700.00
7D
-11.8%
1Y
74.2%
GC Biopharma
Market Cap: ₩1.5t
A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
A006280
₩129,200.00
7D
-0.5%
1Y
-4.0%
Seegene
Market Cap: ₩1.5t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩32,150.00
7D
11.2%
1Y
15.2%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩124,600.00
7D
-3.4%
1Y
-7.0%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩37,400.00
7D
7.0%
1Y
8.4%
JS Link
Market Cap: ₩1.4t
A genome-based biotechnology company, focuses on the research and development of genome analysis services in South Korea and internationally.
A127120
₩40,500.00
7D
3.4%
1Y
138.8%
HK inno.N
Market Cap: ₩1.2t
Engages in the pharmaceutical business in South Korea.
A195940
₩41,650.00
7D
0.1%
1Y
-7.4%
Qurient
Market Cap: ₩1.0t
A biotech company, engages in the research and development of drugs to address unmet medical needs in Korea and internationally.
A115180
₩25,600.00
7D
11.8%
1Y
134.6%
Rznomics
Market Cap: ₩982.3b
Develops RNA based gene therapies for cancers and intractable diseases.
A476830
₩35,250.00
7D
8.8%
1Y
n/a
Chong Kun Dang Pharmaceutical
Market Cap: ₩899.9b
Manufactures, markets, and sells medicines in South Korea and internationally.
A185750
₩68,300.00
7D
-3.1%
1Y
-17.7%